Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy

Gabapentinoid-induced peripheral edema and acute heart failure: A translational study combining pharmacovigilance data and in vitro animal experiments

(2022) Bérenger Largeau et al.   BIOMEDICINE & PHARMACOTHERAPY

Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study

(2021) Alan S. Go et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes—2022

(2021)   DIABETES CARE

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

(2021)   DIABETES CARE

Incident Heart Failure and Long-Term Risk for Venous Thromboembolism

(2020) Christina L. Fanola et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of Pregabalin and Worsening Heart Failure: A Nationwide Cohort Study

(2020) Marie Lund et al.   DRUG SAFETY

A Clinical Overview of Off-label Use of Gabapentinoid Drugs

(2019) Christopher W. Goodman et al.   JAMA Internal Medicine

Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?

(2019) Cyrus Cooper et al.   DRUGS & AGING

Cirrhosis and risk of stroke: A systematic review and meta-analysis

(2018) Jianping Xiong et al.   ATHEROSCLEROSIS

Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation

(2018) Jeffrey S. Berger et al.   JOURNAL OF CARDIAC FAILURE

Ejection fraction, B-type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure

(2018) Barry Greenberg et al.   CLINICAL CARDIOLOGY

Risk of stroke in congestive heart failure with and without atrial fibrillation

(2017) Si-Hyuck Kang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Pregabalin and heart failure: A population-based study

(2017) Joanne M.-W. Ho et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The risk of venous thromboembolism in patients with cirrhosis

(2017) Pasquale Ambrosino et al.   THROMBOSIS AND HAEMOSTASIS

Testosterone and Cardiovascular Disease

(2016) Robert A. Kloner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sleep apnea and venous thromboembolism

(2015) Camilla Mattiuzzi et al.   THROMBOSIS AND HAEMOSTASIS

Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes

(2014) Christianne L. Roumie et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain

(2014) Kenji Onouchi et al.   Journal of Pain Research

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

(2012) R. van der Pas et al.   CLINICAL ENDOCRINOLOGY

Epidemiology and Pathophysiology of Nephrotic Syndrome-Associated Thromboembolic Disease

(2012) B. A. Kerlin et al.   Clinical Journal of the American Society of Nephrology

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

(2011) Tina Ken Schramm et al.   EUROPEAN HEART JOURNAL

Adverse Events Associated with Testosterone Administration

(2010) Shehzad Basaria et al.   NEW ENGLAND JOURNAL OF MEDICINE

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

(2009) Kevin M. Pantalone et al.   ACTA DIABETOLOGICA

Venous Thromboembolism in Patients Hospitalized With Thyroid Dysfunction

(2009) Liviu G. Danescu et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death

(2009) Neomi A. Shah et al.   Sleep and Breathing